Correlation Between SpringWorks Therapeutics and Ventyx Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SpringWorks Therapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SpringWorks Therapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SpringWorks Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on SpringWorks Therapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SpringWorks Therapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SpringWorks Therapeutics and Ventyx Biosciences.

Diversification Opportunities for SpringWorks Therapeutics and Ventyx Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SpringWorks and Ventyx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SpringWorks Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and SpringWorks Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SpringWorks Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of SpringWorks Therapeutics i.e., SpringWorks Therapeutics and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between SpringWorks Therapeutics and Ventyx Biosciences

Given the investment horizon of 90 days SpringWorks Therapeutics is expected to generate 2.29 times less return on investment than Ventyx Biosciences. But when comparing it to its historical volatility, SpringWorks Therapeutics is 1.71 times less risky than Ventyx Biosciences. It trades about 0.05 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  217.00  in Ventyx Biosciences on September 5, 2024 and sell it today you would earn a total of  28.00  from holding Ventyx Biosciences or generate 12.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SpringWorks Therapeutics  vs.  Ventyx Biosciences

 Performance 
       Timeline  
SpringWorks Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SpringWorks Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, SpringWorks Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Ventyx Biosciences 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

SpringWorks Therapeutics and Ventyx Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SpringWorks Therapeutics and Ventyx Biosciences

The main advantage of trading using opposite SpringWorks Therapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SpringWorks Therapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.
The idea behind SpringWorks Therapeutics and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals